KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Non-Current Liabilities: 2014-2024

Historic Total Non-Current Liabilities for Exact Sciences (EXAS) over the last 11 years, with Dec 2024 value amounting to $3.2 billion.

  • Exact Sciences' Total Non-Current Liabilities fell 4.12% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year decrease of 4.12%. This contributed to the annual value of $3.2 billion for FY2024, which is 7.37% up from last year.
  • According to the latest figures from FY2024, Exact Sciences' Total Non-Current Liabilities is $3.2 billion, which was up 7.37% from $3.0 billion recorded in FY2023.
  • In the past 5 years, Exact Sciences' Total Non-Current Liabilities registered a high of $3.2 billion during FY2024, and its lowest value of $2.6 billion during FY2020.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $3.0 billion (2023), whereas its average is $3.0 billion.
  • In the last 5 years, Exact Sciences' Total Non-Current Liabilities spiked by 123.05% in 2020 and then declined by 1.67% in 2022.
  • Yearly analysis of 5 years shows Exact Sciences' Total Non-Current Liabilities stood at $2.6 billion in 2020, then rose by 9.15% to $2.9 billion in 2021, then dropped by 1.67% to $2.8 billion in 2022, then rose by 5.61% to $3.0 billion in 2023, then rose by 7.37% to $3.2 billion in 2024.